BMRN vs FBNC · P/E 40, rev $1.76B vs P/E 22, rev $290.7M
Biomarin Pharmaceutical Inc (BMRN) versus First Bancorp (FBNC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
First Bancorp (FBNC) is a banks - regional company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FBNC revenue for 2026-06-30 was $290.7M. Net income was $97.2M. FBNC currently screens at market cap $1.95B and trailing P/E 22.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FBNC currently screens at market cap $1.95B and trailing P/E 22.3.
Not investment advice. Open the BMRN and FBNC stock pages for the full models.
Not investment advice.